Collection of Gastrointestinal and Fatigue Data in Scleroderma (Ssc) Patients at Mayo Clinic Arizona

Overview

About this study

The purposeo of this study is to create a database of Scleroderma patients from which abstracts of data could be compiled and analyzed for various studies.  Data of interest would include demographics, GI symptoms, GI symptom impact on quality of life (QOL), and sleep quality.

Participation eligibility

Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines differ from study to study, and identify who can or cannot participate. There is no guarantee that every individual who qualifies and wants to participate in a trial will be enrolled. Contact the study team to discuss study eligibility and potential participation.

Inclusion Criteria:

  • Scleroderma patients

Participating Mayo Clinic locations

Study statuses change often. Please contact the study team for the most up-to-date information regarding possible participation.

Mayo Clinic Location Status Contact

Scottsdale/Phoenix, Ariz.

Mayo Clinic principal investigator

Michael Crowell, Ph.D.

Contact us for the latest status

Contact information:

Michael Crowell Ph.D.

(480) 301-6990

Crowell.Michael@mayo.edu

Rochester, Minn.

Mayo Clinic principal investigator

Michael Crowell, Ph.D.

Contact us for the latest status

Contact information:

Michael Crowell Ph.D.

(480) 301-6990

Crowell.Michael@mayo.edu

More information

Publications

Publications are currently not available

Study Results Summary

Not yet available

Supplemental Study Information

Not yet available

.
CLS-20310387

Mayo Clinic Footer